Hoth Therapeutics Research Coverage Started at HC Wainwright

HOTH Stock  USD 0.81  0.04  4.71%   
Under 61% of Hoth Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Hoth Therapeutics stock suggests that many investors are alarmed at this time. Hoth Therapeutics' investing sentiment shows overall attitude of investors towards Hoth Therapeutics.
  
Equities research analysts at HC Wainwright started coverage on shares of Hoth Therapeutics in a report issued on Monday, Benzinga reports. The firm set a buy rating and a 4.00 price target on the stock. HC Wainwrights price objective points to a potential upside of 210.08 percent from the companys previous

Read at thelincolnianonline.com
news
  

Hoth Therapeutics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Hoth Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Hoth Therapeutics Fundamental Analysis

We analyze Hoth Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hoth Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hoth Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Ratio

Current Ratio Comparative Analysis

Hoth Therapeutics is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Hoth Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hoth Therapeutics stock to make a market-neutral strategy. Peer analysis of Hoth Therapeutics could also be used in its relative valuation, which is a method of valuing Hoth Therapeutics by comparing valuation metrics with similar companies.

Peers

Hoth Therapeutics Related Equities

CDIOCardio Diagnostics   5.00   
0%
34.0%
ZURAZura Bio   3.64   
0%
25.0%
SONNSonnet Biotherapeutics   3.39   
0%
23.0%
ATNF180 Life   2.66   
0%
18.0%
ALLRAllarity Therapeutics   0.97   
6.0%
0%
PHIOPhio Pharmaceuticals   2.09   
14.0%
0%
NRBONeurobo Pharmaceuticals   2.59   
18.0%
0%
ADTXAditxt   2.78   
19.0%
0%
ATXIAvenue Therapeutics   3.23   
22.0%
0%
BDRXBiodexa Pharmaceticals   4.06   
28.0%
0%
KPRXKiora Pharmaceuticals   5.41   
37.0%
0%
VRAXVirax Biolabs   7.65   
53.0%
0%
REVBRevelation Biosciences   9.76   
68.0%
0%
QNRXQuoin Pharmaceuticals   14.29   
100.0%
0%

Complementary Tools for Hoth Stock analysis

When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity